Browse Drug Recalls
2,097 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 2,097 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 2,097 FDA drug recalls in NJ.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Feb 7, 2022 | Luxury 70% Isopropyl Alcohol, 16 FL. OZ. (1PT) 473 ML bottle, Distributed by:... | Labeling - product contains undeclared ethyl alcohol | Class II | Tsm Brands LLC |
| Feb 7, 2022 | Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx ... | Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufa... | Class II | RISING PHARMACEUTICALS |
| Feb 7, 2022 | Chlorthalidone Tablets USP 25 mg, Rx Only, 100 Tablets, Sun Pharma, Mfg. by: ... | Foreign Matter identified as stainless steel microscopic wear particles mixed with punch lubrican... | Class II | SUN PHARMACEUTICAL INDUSTRIES INC |
| Jan 28, 2022 | Premium Nature Instant Hand Sanitizer, (ethyl alcohol 65%), plastic bottles p... | Subpotent Drug: FDA analysis has revealed some bottles of these products were sub potent for etha... | Class II | AMS Packaging Inc |
| Jan 28, 2022 | Premium Nature Instant Hand Sanitizer, (ethyl alcohol 70%), plastic bottle pa... | Subpotent Drug: FDA analysis has revealed some bottles of these products were sub potent for etha... | Class II | AMS Packaging Inc |
| Jan 26, 2022 | Polymyxin B for Injection USP, 500,000 Units per Vial, 10 mL vials, packaged ... | Presence of Particulate Matter; product complaint of hair discovered in a vial within the lot | Class I | AuroMedics Pharma LLC |
| Jan 19, 2022 | Bortezomib, 3.5 mg/vial, Single-Dose Vial, Rx Only, Mfd. By: Dr. Reddy's Labo... | Failed stability specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 19, 2022 | Azacitidine, 100mg/vial, One Single-dose Vial, Rx Only, Mfd. By: Dr. Reddy's ... | Failed stability specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 19, 2022 | Azacitidine, 1,00mg/Vial, One Single-dose Vial, Rx Only, Mfd. By: Dr. Reddy's... | Failed stability specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 18, 2022 | Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 ... | Failed Dissolution Specification: Dissolution results are below specification limits for the acti... | Class II | Teva Pharmaceuticals USA |
| Jan 14, 2022 | Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only... | Failed Impurities/Degradation Specifications | Class II | Aurobindo Pharma USA Inc. |
| Jan 12, 2022 | Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Rx Only, 100 Table... | Failed Dissolution Specifications. | Class II | Ascend Laboratories, LLC |
| Jan 10, 2022 | Mucus Relief D, Guaifenesin Pseudoephedrine HCl ER Tablets, 600 mg/60mg, pack... | Subpotent drug | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 10, 2022 | Tretinoin Capsules, 10 mg, 100 count bottle, Rx Only, Teva Pharmaceuticals US... | Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution. | Class II | Teva Pharmaceuticals USA |
| Jan 7, 2022 | Mimvey (estradiol and norethindrone acetate tablets USP), 1 mg/0.5 mg, packag... | Mislabeling | Class III | Teva Pharmaceuticals USA |
| Jan 7, 2022 | Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg, package... | Mislabeling | Class III | Teva Pharmaceuticals USA |
| Jan 4, 2022 | Kroger, Allergy Relief-D, Fexofenadine HCl 60mg/Antihistamine Pseudoephedrine... | Failed Dissolution Specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 4, 2022 | Leader, 12HR Allergy & Congestion Relief, Fexofenadine HCl, 60mg Pseudoephedr... | Failed Dissolution Specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 4, 2022 | Rite Aid Pharmacy, Allergy & Congestion, Fexofenadine HCl 60mg & Pseudoephedr... | Failed Dissolution Specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 4, 2022 | Dr. Reddys, Fexofenadine HCl 60 mg & Pseudoephedrine HCl 120 mg Extended-Rele... | Failed Dissolution Specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 4, 2022 | Wal-Fex D, Fexofenadine HCl 60mg/Antihistamine & Pseudoephedrine HCl 120mg/Na... | Failed Dissolution Specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 4, 2022 | Rugby, Antihistamine and Nasal Decongestant, Fexofenadine HCl 60mg and Pseudo... | Failed Dissolution Specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 4, 2022 | equate, Allergy Relief D, Fexofenadine HCl 60mg/Antihistamine, Pseudoephedrin... | Failed Dissolution Specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 4, 2022 | CVS Health, Allergy Relief D, Fexofenadine HCl 60mg/Antihistamine Pseudoephe... | Failed Dissolution Specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 4, 2022 | QC QUALITY CHOICE, Fexofenadine HCl 60mg and Pseudoephedrine HCl 120mg, Exten... | Failed Dissolution Specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Dec 31, 2021 | Norepinephrine Bitartrate Injection USP 4 mg/4 mL (1 mg/mL), 4 mL Single-Dose... | Lack of Assurance of Sterility | Class II | Teva Pharmaceuticals USA |
| Dec 31, 2021 | MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 1... | Lack of Assurance of Sterility | Class II | Teva Pharmaceuticals USA |
| Dec 29, 2021 | Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo... | Superpotent and Failed Tablet/Capsule Specifications | Class II | Aurobindo Pharma USA Inc. |
| Dec 27, 2021 | Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 count HDPE ... | CGMP Deviations- Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Da... | Class II | VIONA PHARMACEUTICALS INC |
| Dec 21, 2021 | Medroxyprogesterone Acetate Injection, IM, 150 mg/mL, packaged in 1 ml Single... | Lack of Assurance of Sterility | Class II | Ideal Specialty Apothecary, Inc. dba Ideal Phar... |
| Dec 21, 2021 | Cefixime Capsules, 400 mg, 50-count bottles, Rx only, Manufactured by: Alkem ... | Failed impurities/degradation specifications | Class II | Ascend Laboratories, LLC |
| Dec 16, 2021 | Penicillin V Potassium for Oral Solution, USP 125 mg (200,000 U) per 5 mL a) ... | Subpotent | Class II | Teva Pharmaceuticals USA |
| Dec 8, 2021 | Brinzolamide Ophthalmic Suspension, USP 1%, packaged as a)10 ml dropper bottl... | Defective Container: The notch in the cap that fits into the nozzle of the dropper could break of... | Class II | Teva Pharmaceuticals USA |
| Dec 6, 2021 | NaturesPlus Advanced Therapeutics Glucosamine Chondroitin MSM Ultra Rx- Joint... | MICROBIAL CONTAMINATION OF NON-STERILE PRODUCT: microbial contaminant identified as Pluralibacter... | Class II | Organics Corporation of America DBA Ambix Labor... |
| Dec 2, 2021 | Carbamazepine Tablets, USP 200 mg 100 Tablets Rx only NDC 13668-268-01 Manufa... | Failed Dissolution Specifications | Class II | Torrent Pharma Inc. |
| Dec 1, 2021 | Telmisartan and Hydrochlorothiazide Tablets, USP, 40 mg/12.5 mg, 30 count bot... | Superpotent; Hydrochlorothiazide | Class III | Torrent Pharma Inc. |
| Nov 30, 2021 | Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 ... | Superpotent Drug | Class I | Teligent Pharma, Inc. |
| Nov 30, 2021 | Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 ... | Superpotent Drug: Minimally superpotent | Class II | Teligent Pharma, Inc. |
| Nov 17, 2021 | Enoxaparin Sodium Injection, USP, 40 mg/0.4 mL, Single-Dose Syringes with Aut... | Temperature Abuse; temperature excursion during shipping | Class I | Sandoz Inc |
| Nov 15, 2021 | Carvedilol Tablets, USP, 6.25 mg, 500 Tablets bottle, Rx Only, Distributed by... | Failed Impurities/Degradation Specifications | Class III | Aurobindo Pharma USA Inc. |
| Nov 12, 2021 | Allergy Relief D Fexofenadine HCl, 60 mg I Pseudoephedrine HCl, 120 mg, Exten... | Failed dissolution specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Nov 12, 2021 | Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg Extended Release Tablets U... | Failed dissolution specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Nov 12, 2021 | Allergy Relief D Fexofenadine HCl, 60 mg I Pseudoephedrine HCl, 120 mg, Exten... | Failed dissolution specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Nov 12, 2021 | Allergy & Congestion Relief Allergy Relief D, Fexofenadine HCl 60 mg/ Pseudoe... | Failed dissolution specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Nov 12, 2021 | Fexofenadine HCl, 60 mg & Pseudoephedrine HCl 120 mg, Extended Release Tablet... | Failed dissolution specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Nov 12, 2021 | Allergy & Congestion Fexofenadine HCl 60 mg & Pseudoephedrine HCl 120 mg Exte... | Failed dissolution specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Nov 12, 2021 | Antihistamine & Nasal Decongestant, Fexofenadine HCl 60 mg and Pseudoephedrin... | Failed dissolution specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Nov 12, 2021 | Antihistamine & Nasal Decongestant, Fexofenadine HCl 60 mg and Pseudoephedrin... | Failed dissolution specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Nov 12, 2021 | 12 HR Allergy & Congestion Relief Fexofenadine HCl, 60 mg I Pseudoephedrine H... | Failed dissolution specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Nov 3, 2021 | Cefixime Capsules 400 mg, 50 capsules bottles, Rx Only, Manufactured by: Alke... | Failed Impurities/Degradation Specifications | Class II | Ascend Laboratories LLC |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.